Cell-based cytotoxicity and cytokine secretion assays in conjunction with scRNA-seq were applied to interrogate MART-1-specific transgenic T cells upon antigen-specific stimulation with different ratios of tumor PD-L1. This evidence concerns the gene MLANA and neoplasm.